论文部分内容阅读
Small interfering RNA (siRNA) has outstanding potential as a therapeutic agent.Several contributions to improvements in their tissue and cellular delivery have thus far been made with a variety of encapsulating structures,large terminal conjugates and cell surface receptor ligands.We have developed specific Polypeptide Nano-Particle (PNP) systems for siRNA delivery locally and systemically.